GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: momelotinib-3,3,5,5-d4 | Zepuping® (China)
jaktinib is an approved drug
Compound class:
Synthetic organic
Comment: Jaktinib is a deuterated analogue of momelotinib. It has also been called gecacitinib [2]. The compound behaves as a dual Janus kinase/ACVR1 inhibitor.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Jing R, Zhi X, Shao L. (2026)
Approvals by the China NMPA in 2025. Nat Rev Drug Discov, [Epub ahead of print]. [PMID:41688808] |
|
2. Zhang Y, Zhou H, Suo S, Zhuang J, Yang L, He A, Liu Q, Du X, Gao S, Li Y et al.. (2024)
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study. Blood Cancer J, 14 (1): 216. [PMID:39695117] |